logo

ABCL Stock: Exploring AbCellera Biologics Inc’s Growth

AbCellera Biologics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $6.05 on 01/08/24, while the lowest price for the same period was registered at $2.34 on 09/10/24.

52-week price history of ABCL Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. AbCellera Biologics Inc’s current trading price is -44.35% away from its 52-week high, while its distance from the 52-week low is 44.32%. The stock’s price range during this period has spanned from $2.34 to $6.05. In the Healthcare sector, the AbCellera Biologics Inc’s shares surpassed a trading volume of approximately 2.25 million for the day, which was noticeably lower compared to the average daily volume of 9.2.45 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

AbCellera Biologics Inc (ABCL) has experienced a quarterly rise of 28.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 995.35M and boasts a workforce of 586 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.74, with a change in price of +0.75. Similarly, AbCellera Biologics Inc recorded 2,303,356 in trading volume during the last 100 days, posting a change of +28.63%.

Examining ABCL’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.

ABCL Stock Stochastic Average

Today, AbCellera Biologics Inc’s raw stochastic average for the past 50 days stands at 90.16%, indicating a rise from the raw stochastic average of the last 20 days, which was 88.76%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 88.89% and 84.30% respectively.

ABCL Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 15.01%. However, over the past six months, we’ve seen a weaker performance of 19.50%. The price of ABCL fallen by 18.24% over the last 30 days. And in the last five days, it has surged by 19.50%.

Most Popular